APIs pour la recherche et les impuretés

3-[(1E)-2-[4-[[(2-Carboxyethyl)amino]carbonyl]phenyl]diazenyl] balsalazide is a white to off-white solid that is soluble in water and acidic solutions. It has an impurity level of less than 0.5%. The melting point of 3-[(1E)-2-[4-[[(2-Carboxyethyl)amino]carbonyl]phenyl]diazenyl] balsalazide is approximately 195°C. This compound has been shown to have antibiotic activity against a variety of bacteria, including methicillin resistant Staphylococcus aureus (MRSA).

1-Hexacosene is a medicinal compound with potential anticancer properties. It has been shown to inhibit the activity of certain kinases, which are enzymes involved in cell signaling and regulation. This inhibition leads to increased apoptosis, or programmed cell death, in cancer cells. 1-Hexacosene has also demonstrated inhibitory effects on tumor growth in Chinese hamsters. In addition, this compound has been found in human urine and may have potential as a biomarker for cancer diagnosis or monitoring. Further research is needed to fully understand the therapeutic potential of 1-Hexacosene as an inhibitor of protein kinases in cancer treatment.

Ceftazidime t-butyl ester is a prodrug of ceftazidime. It is a crystalline, stable form of the drug that can be dissolved in an organic solvent. Ceftazidime t-butyl ester has an average UV detection wavelength with a linear range of 200-600 nm and can be detected at a wavelength of 220 nm. This drug is used to treat infections caused by bacteria, including those that are resistant to other antibiotics, such as penicillin or ampicillin. Ceftazidime t-butyl ester has been shown to be effective against methicillin-resistant Staphylococcus aureus (MRSA) and Clostridium perfringens, although is not active against acid-fast bacteria such as Mycobacterium tuberculosis or Mycobacterium avium complex.